Case Study: Lyell Immunopharma secures cloud operations and proprietary data with Fidelis Halo

Lyell Immunopharma secures cloud operations with Fidelis Halo

Lyell Immunopharma, a publicly traded cell therapy company, faced the challenge of securing its proprietary data within its cloud-first operations. The company required a security solution that could be seamlessly integrated into its automated CICD and software development life cycle processes. They turned to Fidelis Cybersecurity and its Fidelis CloudPassage Halo platform to address this need.

Fidelis Cybersecurity provided a solution that allowed Lyell to programmatically define security configurations via APIs. This integration enabled policies to be automatically applied to any new cloud instances spun up, enhancing security without impeding development. The implementation by Fidelis successfully safeguarded Lyell Immunopharma's cloud operations and proprietary data.

Lyell Immunopharma